Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Janssen Research & Development, LLC
Indiana University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Mayo Clinic
NYU Langone Health
University of Arizona